MedPath

The Role of Narrow-Band Imaging Endoscopy in Diagnosing Gastric Intestinal Metaplasia

Conditions
Dyspepsia
Registration Number
NCT00673699
Lead Sponsor
Hillel Yaffe Medical Center
Brief Summary

The purpose of this study is to determine if endoscope with NBI(narrow banding imaging)can detect intestinal metaplasia( consider pre malignant condition) and use a targeting biopsy in case of suspected intestinal metaplasia

Detailed Description

To detect intestinal metaplasia which consider pre malignant condition and use a targeting biopsy in case of suspected intestinal metaplasia which allowed us to better follow-up those patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Dyspepsia
Exclusion Criteria
  • Pregnancy,
  • Upper gastrointestinal bleeding,
  • Previous gastric operation,
  • Known gastric malignancy'
  • Non cooperative patients

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine if endoscope with NBI can detect intestinal metaplasiaIn one week (the time from biopsy till the histology assement)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hillel Yaffe Med Ctr

🇮🇱

Hadera, Israel

Hillel Yaffe Med Ctr
🇮🇱Hadera, Israel
Zvi Fireman, MD
Contact
+972-4-6304384
fireman@hy.health.gov.il
Yael Kopelman, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.